{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:37:22Z","timestamp":1759178242532,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"KAKENHI","award":["23249037","23659353","16K00861"],"award-info":[{"award-number":["23249037","23659353","16K00861"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12881-017-0509-1","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T06:56:18Z","timestamp":1513061778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The gene\u2013treatment interaction of paraoxonase-1 gene polymorphism and statin therapy on insulin secretion in Japanese patients with type 2 diabetes: Fukuoka diabetes registry"],"prefix":"10.1186","volume":"18","author":[{"given":"Akiko","family":"Sumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udai","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9727-7644","authenticated-orcid":false,"given":"Masanori","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Ohkuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamaki","family":"Jodai-Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Komorita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Yoshinari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,12]]},"reference":[{"key":"509_CR1","unstructured":"Diagnosis and Treatment of Diseases of Lipid and Lipoprotein Metabolism in Adults and Children: Diabetes and Dyslipidemia [article online], 2000-2016. Available from \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK305900\/\n\n. Accessed 26 Dec 2016."},{"key":"509_CR2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.atherosclerosis.2015.06.001","volume":"241","author":"AJ Vallejo-Vaz","year":"2015","unstructured":"Vallejo-Vaz AJ, Kondapally Seshasai SR, Kurogi K, Michishita I, Nozue T, Sugiyama S, Tsimikas S, Yoshida H, Ray KK. Effect of pitavastatin on glucose, HbA1c and incident diabetes: a meta-analysis of randomized controlled clinical trials in individuals without diabetes. Atherosclerosis. 2015;241:409\u201318.","journal-title":"Atherosclerosis"},{"key":"509_CR3","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00125-015-3528-5","volume":"58","author":"H Cederberg","year":"2015","unstructured":"Cederberg H, Stan\u010d\u00e1kov\u00e1 A, Yaluri N. Increased risk of diabetes with statin therapy is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort. Diabetologia. 2015;58:1109\u201317.","journal-title":"Diabetologia"},{"key":"509_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2169\/internalmedicine.45.1476","volume":"45","author":"M Ishikawa","year":"2006","unstructured":"Ishikawa M, Namiki A, Kubota T, Yajima S, Fukazawa M, Moroi M, Sugi K. Effect of pravastatin and atorvastatin on glucose metabolism in nondiabetic patients with hypercholesterolemia. Intern Med. 2006;45:51\u20135.","journal-title":"Intern Med"},{"key":"509_CR5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.10.053","volume":"55","author":"KK Koh","year":"2010","unstructured":"Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Shin EK. Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. J Am Coll Cardiol. 2010;55:1209\u201316.","journal-title":"J Am Coll Cardiol"},{"key":"509_CR6","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.atherosclerosis.2011.07.119","volume":"219","author":"M Koren-Gluzer","year":"2011","unstructured":"Koren-Gluzer M, Aviram M, Meilin E, Hayek T. The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates \u03b2-cell insulin release. Atherosclerosis. 2011;219:510\u20138.","journal-title":"Atherosclerosis"},{"key":"509_CR7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2337\/dc12-2211","volume":"36","author":"PW Franks","year":"2013","unstructured":"Franks PW, Pearson E, Florez JC. Gene-environment and gene-treatment interactions in type 2 diabetes: progress, pitfalls, and prospects. Diabetes Care. 2013;36:1413\u201321.","journal-title":"Diabetes Care"},{"key":"509_CR8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","volume":"385","author":"DI Swerdlow","year":"2015","unstructured":"Swerdlow DI, Preiss D, Kuchenbaecker KB, HMG-coenzyme A. Reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet. 2015;385:351\u201361.","journal-title":"Lancet"},{"key":"509_CR9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2015.08.003","volume":"60","author":"G Ferretti","year":"2015","unstructured":"Ferretti G, Bacchetti T, Sahebkar A. Effect of statin therapy on paraoxonase-1 status: a systematic review and meta-analysis of 25 clinical trials. Prog Lipid Res. 2015;60:50\u201373.","journal-title":"Prog Lipid Res"},{"key":"509_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gene.2015.04.088","volume":"567","author":"M Mackness","year":"2015","unstructured":"Mackness M, Mackness B. Human paraoxonase-1 (PON1): gene structure and expression, promiscuous activities and multiple physiological roles. Gene. 2015;567:12\u201321.","journal-title":"Gene"},{"key":"509_CR11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jacl.2015.07.007","volume":"9","author":"H Kakuda","year":"2015","unstructured":"Kakuda H, Matoba M, Nakatoh H, Nagao S, Takekoshi N. Effects of change in high-density lipoprotein cholesterol by statin switching on glucose metabolism and renal function in hypercholesterolemia. J Clin Lipidol. 2015;9:709\u201315.","journal-title":"J Clin Lipidol"},{"key":"509_CR12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.clinbiochem.2015.06.009","volume":"48","author":"JA de Souza","year":"2015","unstructured":"de Souza JA, Menin A, Lima LO, Smiderle L, Hutz MH, Van Der Sand CR, Van Der Sand LC, Ferreira ME, Pires RC, Almeida S, Fiegenbaum M. PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients. Clin Biochem. 2015;48:1039\u201344.","journal-title":"Clin Biochem"},{"key":"509_CR13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00125-012-2746-3","volume":"56","author":"T Ohkuma","year":"2013","unstructured":"Ohkuma T, Fujii H, Iwase M. Impact of eating rate on obesity and cardiovascular risk factors according to glucose tolerance status: the Fukuoka diabetes registry and the Hisayama study. Diabetologia. 2013;56:70\u20137.","journal-title":"Diabetologia"},{"key":"509_CR14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"12","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;12:1487\u201395.","journal-title":"Diabetes Care"},{"key":"509_CR15","doi-asserted-by":"crossref","first-page":"S498","DOI":"10.1097\/00005768-200009001-00009","volume":"32","author":"BE Ainsworth","year":"2000","unstructured":"Ainsworth BE, Haskell WL, Whitt MC. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32:S498\u2013504.","journal-title":"Med Sci Sports Exerc"},{"key":"509_CR16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s100380170047","volume":"46","author":"Y Ohnishi","year":"2001","unstructured":"Ohnishi Y, Tanaka T, Ozaki K, Yamada R, Suzuki H, Nakamura YA. High-throughput SNP typing system for genome-wide association studies. J Hum Genet. 2001;46:471\u20137.","journal-title":"J Hum Genet"},{"key":"509_CR17","unstructured":"Healthcare Analytics: A general SAS\u00ae macro to implement optimal N:1 propensity score matching within a maximum radius [article online], 2015. Available from \nhttp:\/\/www.pharmasug.org\/2015-proceedings.html\n\n. Accessed 26 Dec 2016."},{"key":"509_CR18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/CS20040187","volume":"107","author":"SP Deakin","year":"2004","unstructured":"Deakin SP, James RW. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin Sci. 2004;107:435\u201347.","journal-title":"Clin Sci"},{"key":"509_CR19","first-page":"1298","volume":"4","author":"GJ Belwalker","year":"2013","unstructured":"Belwalker GJ, Jagtap PE, Nagane NS, Dhonde S. PON1 activity in newly detected type 2 diabetes mellitus patients with and without hypertension. Int J Pharm Bio Sci. 2013;4:1298\u2013302.","journal-title":"Int J Pharm Bio Sci"},{"key":"509_CR20","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0891-5849(98)00272-X","volume":"26","author":"M Aviram","year":"1999","unstructured":"Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La DB. Human serum paraoxonase (PON1) is inactivated by oxidised low density lipoprotein and preserved by antioxidants. Free Rad Biol Med. 1999;26:892\u2013904.","journal-title":"Free Rad Biol Med"},{"key":"509_CR21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0021-9150(00)00680-8","volume":"156","author":"M Sent\u00ed","year":"2001","unstructured":"Sent\u00ed M, Tom\u00e1s M, Vila J, Marrugat J, Elosua R, Sala J, Masi\u00e1 R. Relationship of age-related myocardial infarction risk and Gln\/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study. Atherosclerosis. 2001;156:443\u20139.","journal-title":"Atherosclerosis"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-017-0509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T06:56:37Z","timestamp":1513061797000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-017-0509-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["509"],"URL":"https:\/\/doi.org\/10.1186\/s12881-017-0509-1","relation":{},"ISSN":["1471-2350"],"issn-type":[{"type":"electronic","value":"1471-2350"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"146"}}